drugset / Trial / NCT03830463
Study to Assess the Safety and Pharmacokinetic (PK) of CTP-692 in Healthy Volunteers
RandomizedSequentialQuadruple-blindTreatment
Summary
This study will assess the safety and pharmacokinetic (PK) profile of single ascending doses of CTP-692 in healthy volunteers.
Timeline
- Start
- 2019-01-24
- Primary completion
- 2019-03-28
- Completion
- 2019-03-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CTP-692 | Unknown | — | Oral |
Indications
No indication recorded.